Help Women Gain Coverage for Ovarian Cancer Tests
  • Petitioning Health Insurance Company CEOs

This petition will be delivered to:

Health Insurance Company CEOs

Help Women Gain Coverage for Ovarian Cancer Tests

    1. Petition by

      OVA1® Test

Please consider providing adequate coverage for women facing surgery for ovarian cancer. Ovarian cancer is the deadliest of all gynecologic cancers combined, according to a 2012 study by the National Cancer Institute and members of the International Cancer Research Partnership. The American Cancer Society estimates that this year, in the United States alone, about 22,240 new cases of ovarian cancer will be diagnosed and 14,030 women will die of ovarian cancer.

These mortality rates have remained unchanged for decades, and the majority of women are diagnosed with advanced-stage disease where the five-year survival rate may be only 35 percent. In contrast, early stage disease has a 95 percent five-year survival rate when properly treated by a gynecologic oncologist.

A new study from the University of California, Irvine, has found most women with ovarian cancer receive inadequate care and miss out on treatments that could add a year or more to their lives. By identifying women at an elevated risk for cancer they can be referred to a specialist and receive the most complete surgery possible, thereby improving their chance of survival.

OVA1 is the first FDA cleared blood test that determines the likelihood of an ovarian mass being malignant before the woman has to undergo surgery. This test helps women receive appropriate care by providing patients and health care providers with more information to support medical decisions that improve survival rates and reduce surgical complications. Every day this test is not covered: women lose.

Why should people sign?

Every 23 minutes a woman is diagnosed with ovarian cancer.

Access to proper ovarian cancer treatment has been a prominent topic in national news, highlighted by “The New York Times,” “NBC Nightly News,” and a subsequent “NY Times” editorial board response. The study cited was presented at the meeting of the Society of Gynecologic Oncology, in March, and revealed that only 37 percent of women with ovarian cancer are receiving proper referral to a specialist. The NBC News piece pointed out: the problem involves providers, insurance, and failure to follow published guidelines. When women are referred to a specialist and receive the right care the results are evident, outcomes are better and women live longer.

This is your chance to stop this trend. Often called “the silent killer,” ovarian cancer frequently goes unnoticed until it’s too late. OVA1 has the ability to make a difference in the lives of women facing ovarian cancer. Women lose when they are denied access to care and insurance coverage for this important diagnostic test as part of their pre-surgical management.

By signing this petition, now through Ovarian Cancer Awareness Month in September and beyond, you are letting insurance payers know women deserve access to and coverage for tests like OVA1 in the fight against ovarian cancer.

OVA1 is a qualitative serum test that combines the results of five immunoassays into a single numerical result. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. OVA1 is an aid to further assess the likelihood that malignancy is present when the physician’s independent clinical and radiological evaluation does not indicate malignancy.

PRECAUTION: OVA1 should not be used without an independent clinical/radiological evaluation and is not intended to be a screening test or to determine whether a patient should proceed to surgery. Incorrect use of OVA1 carries the risk of unnecessary surgery, and/or delayed diagnosis.

Health Insurance Company CEOs
Help Women Gain Coverage for Ovarian Cancer Tests

[Your name]

Recent signatures


    1. Reached 3,000 signatures
    2. #FightBack against ovarian cancer

      Thank you all so much for signing and sharing your stories around ovarian cancer! September is ovarian cancer month, and we want to get this petition rocking to send to insurance companies. Let's let them know that you are demanding better care for ovarian cancer. Please share with your community and help us get to 5,000 signatures and more! Thank you for helping us as we #FightBack against ovarian cancer!

    3. Reached 500 signatures
    4. Thank you for your comments

      Thank you for all of your comments and sharing your stories. Ovarian cancer touches so many lives. Please help share the petition to your social media and tweet with hastags #FightBack or #WomenLose with our petition link. We have a new image you can share above for women to "Fight Back" against ovarian cancer. Help us to reach 500 signatures in the next week. We appreciate all you are doing to bring attention to this petition to get women the health coverage they deserve.

    5. Reached 250 signatures
    6. We need your help

      We're excited to have such a good response to our petition and need your help to reach 10,000 signatures by ovarian cancer month in September. Help us tell the insurance companies that they need to cover tests like OVA1 to help women win the fight against ovarian cancer!

    7. Reached 100 signatures


    Reasons for signing

    • Leah Kenworthy SAN FRANCISCO, CA
      • about 21 hours ago

      recent possible diagnosis

    • Yolima Diaz NEW YORK, NY
      • 2 days ago

      One of my best friend's died of Ovarian Cancer 12-1-13. More people need to know about this.

    • Linda Nunney WESTLAKE, OH
      • 11 days ago

      Diagnosed Fall 2012

    • Ronna Madden SPOKANE, WA
      • 14 days ago

      I had it done and now I owe $1800.00.

    • Suzanne Garrett CANISTEO, NY
      • 30 days ago

      I lost my young sister to this disease.


    Develop your own tools to win.

    Use the API to develop your own organizing tools. Find out how to get started.